Jornal Vascular Brasileiro
https://www.jvascbras.org/article/doi/10.1590/1677-5449.202201562
Jornal Vascular Brasileiro
Original Article

Long-term outcomes after endovascular aortic treatment in patients with thoracic aortic diseases

Resultados a longo prazo após tratamento endovascular da aorta em pacientes com doenças da aorta torácica

Antonio Carlos Brandi; Carlos Alberto dos Santos; Josélia Menin Brandi; Marcio Antonio dos Santos; Paulo Henrique Husseine Botelho

Downloads: 0
Views: 580

Abstract

Background: Endovascular treatments for thoracic aortic diseases have been adopted rapidly, and long-term studies are relevant for durability evaluation.

Objective: To evaluate the long-term results of a prospective observational study of endovascular treatment in patients with thoracic aortic diseases who underwent percutaneous implantation of self-expandable endoprostheses.

Methods: Procedural success was defined as the absence of endoleak into the aneurysm or dissection-induced false lumen, no migration, and no conversion to open surgery. Intraoperative, postoperative, and late postoperative outcomes were evaluated in terms of complications, mortality, and evolution of the endoprosthesis over a follow-up of up to 179 months (median: 46 months).

Results: A total of 150 endoprostheses were implanted in 112 patients. Primary success was observed in 100 (82.14%) patients. Immediate mortality occurred in 7 patients (6.25%). Late mortality occurred in 31 patients (27.68%), 10 (8.93%) of whom died from cardiovascular causes, 12 (10.71%) from non-cardiovascular causes, and 2 (1.78%) from natural causes, while 7 (6.25%) had no diagnosis for cause of death. Types I, II, and IV endoleaks occurred during hospitalization in 4 (3.57%), 5 (4.46%), and 3 (2.68%) patients, respectively. Late types I and IV endoleaks occurred in 5 (4.46%) and 3 (2.68%) patients respectively. Twenty-two patients (19.64%) had clinical complications in the immediate postoperative period. Actuarial survival free from death from cardiovascular causes was 79.3% (95% confidence interval, 67.0-91.7%) at 132 months.

Conclusions: The low levels of intraoperative and postoperative complications demonstrate that endovascular treatment is safe and effective. The high rate of late survival for these critically ill patients indicates that the endovascular technique is beneficial for treatment of thoracic aortic diseases in terms of long-term outcomes.

Supplementary material

Keywords

aneurysm, aortic arch, dissection, thoracic endovascular aortic repair

Resumo

Contexto: Os tratamentos endovasculares para doenças da aorta torácica têm sido adotados rapidamente e estudos de longo prazo são relevantes para avaliação de durabilidade.

Objetivo: Avaliar através de estudo observacional e prospectivo, os resultados a longo prazo do tratamento endovascular em pacientes com doenças da aorta torácica submetidos a implante percutâneo de endoprótese autoexpansível.

Métodos: O sucesso do procedimento foi definido como ausência de vazamento interno para o aneurisma ou falso lúmen induzido por dissecção, ausência de migração e sem necessidade de conversão para cirurgia aberta. Os resultados intraoperatórios, pós-operatórios e tardios foram avaliados quanto a complicações, mortalidade e evolução da endoprótese em um seguimento de até 179 meses (mediana de 46 meses).

Resultados: Um total de 150 endopróteses foram implantadas em 112 pacientes. Sucesso primário foi observado em 100 (82,14%) pacientes. Mortalidade imediata ocorreu em sete pacientes (6,25%). A mortalidade tardia ocorreu em 31 pacientes (27,68%), dos quais 10 (8,93%) morreram por causas cardiovasculares; 12 (10,71%), por causas não cardiovasculares; dois (1,78%), por causas naturais e sete (6,25%) não tiveram a causa da morte diagnosticada. Vazamentos tipo I, II e IV ocorreram durante a internação em quatro (3,57%), cinco (4,46%) e três (2,68%) pacientes, respectivamente. Vazamentos tardios tipo I e IV ocorreram em cinco (4,46%) e três (2,68%) pacientes, respectivamente. Complicações clínicas no pós-operatório imediato foram observadas em 19,64% dos pacientes. A sobrevida atuarial por causas cardiovasculares foi de 79,3% em 132 meses.

Conclusões: Os baixos índices de complicações intra e pós-operatórias demonstram que o tratamento endovascular é seguro e eficaz. A alta taxa de sobrevida em 132 meses em pacientes críticos indica que a técnica é benéfica para o tratamento de doenças da aorta torácica em resultados a longo prazo.

Material suplementar 

Palavras-chave

aneurisma, arco aórtico, dissecção, correção endovascular da aorta torácica

References

1 Ciccone MM, Dentamaro I, Masi F, Carbonara S, Ricci G. Advances in the diagnosis of acute aortic syndromes: role of imaging techniques. Vasc Med. 2016;21(3):239-50. http://dx.doi.org/10.1177/1358863X16631419. PMid:26957573.

2 Olsson C, Thelin S, Stahle E, Ekbom A, Granath F. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation. 2006;114(24):2611-8. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.630400. PMid:17145990.

3 Svensson LG, Kouchoukos NT, Miller DC, et al. Expert Consensus Document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg. 2008;85(1, Suppl.):S1-41. http://dx.doi.org/10.1016/j.athoracsur.2007.10.099. PMid:18083364.

4 Brandt M, Hussel K, Walluscheck KP, Böning A, Rahimi A, Cremer J. Early and long-term results of replacement of the descending aorta. Eur J Vasc Endovasc Surg. 2005;30(4):365-9. http://dx.doi.org/10.1016/j.ejvs.2005.04.005. PMid:15890547.

5 Volodos NL, Karpovich IP, Shekhanin VE, et al. A case of the distant transfemoral endoprosthesis of the thoracic artery using a self-fixing synthetic prosthesis in traumatic aneurysm. Grudn Khir. 1988;6(6):84-6. PMid:3220297.

6 Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysm. Ann Vasc Surg. 1991;5(6):491-9. http://dx.doi.org/10.1007/BF02015271. PMid:1837729.

7 Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med. 1994;331(26):1729-34. http://dx.doi.org/10.1056/NEJM199412293312601. PMid:7984192.

8 Patterson B, Holt P, Nienaber C, Cambria R, Fairman R, Thompson M. Aortic pathology determines midterm outcome after endovascular repair of the thoracic aorta: report from the Medtronic Thoracic Endovascular Registry (MOTHER) database. Circulation. 2013;127(1):24-32. http://dx.doi.org/10.1161/CIRCULATIONAHA.112.110056. PMid:23283856.

9 Wiedemann D, Mahr S, Vadehra A, et al. Thoracic endovascular aortic repair in 300 patients: long-term results. Ann Thorac Surg. 2013;95(5):1577-83. http://dx.doi.org/10.1016/j.athoracsur.2013.02.043. PMid:23566647.

10 Wang J, Zhao J, Ma Y, Huang B, Yuan D, Yang Y. Midterm prognosis of type B aortic dissection with and without dissecting aneurysm of descending thoracic aorta after endovascular repair. Sci Rep. 2019;9(1):8870. http://dx.doi.org/10.1038/s41598-019-45472-w. PMid:31222164.

11 Jubouri M, Al‐Tawil M, Yip HCA, et al. Mid‐and long‐term outcomes of thoracic endovascular aortic repair in acute and subacute uncomplicated type B aortic dissection. J Card Surg. 2022;37(5):1328-39. http://dx.doi.org/10.1111/jocs.16349. PMid:35191082.

12 Liu D, Luo H, Lin S, Zhao L, Qiao C. Comparison of the efficacy and safety of thoracic endovascular aortic repair with open surgical repair and optimal medical therapy for acute type B aortic dissection: a systematic review and meta-analysis. Int J Surg. 2020;83:53-61. http://dx.doi.org/10.1016/j.ijsu.2020.08.051. PMid:32927144.

13 Mitchell RS, Ishimaru S, Ehrlich MP, et al. First International Summit on Thoracic Aortic Endografting: roundtable on thoracic aortic dissection as an indication for endografting. J Endovasc Ther. 2002;9(Suppl. 2):II98-105. http://dx.doi.org/10.1177/15266028020090S216. PMid:12166849.

14 Albuquerque LC, Braile DM, Palma JH, Saadi EK. Guidelines for surgery of aortic diseases from Brazilian Society of Cardiovascular Surgery. Rev Bras Cir Cardiovasc. 2007;22(2):137-59. http://dx.doi.org/10.1590/S0102-76382007000200002. PMid:17992319.

15 Coady MA, Ikonomidis JS, Cheung AT, et al. Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation. 2010;121(25):2780-804. http://dx.doi.org/10.1161/CIR.0b013e3181e4d033. PMid:20530003.

16 Czerny M, Pacini D, Aboyans V, et al. Current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2021;59(1):65-73. http://dx.doi.org/10.1093/ejcts/ezaa268. PMid:33011773.

17 Swerdlow NJ, Wu WW, Schermerhorn ML. Open and endovascular management of aortic aneurysms. Circ Res. 2019;124(4):647-61. http://dx.doi.org/10.1161/CIRCRESAHA.118.313186. PMid:30763206.

18 Coady MA, Rizzo JA, Elefteriades JA. Developing surgical intervention criteria for thoracic aortic aneurysms. Cardiol Clin. 1999;17(4):827-39. http://dx.doi.org/10.1016/S0733-8651(05)70118-1. PMid:10589349.

19 Jonker FH, Trimarchi S, Verhagen HJ, Moll FL, Sumpio BE, Muhs BE. Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm. J Vasc Surg. 2010;51(4):1026-32. http://dx.doi.org/10.1016/j.jvs.2009.10.103. PMid:20347700.

20 Almeida RM, Leal JC, Saadi EK, et al. Thoracic endovascular aortic repair: a Brazilian Experience in 255 patients over a period of 112 months. Interact Cardiovasc Thorac Surg. 2009;8(5):524-8. http://dx.doi.org/10.1510/icvts.2008.192062. PMid:19196751.
 


Submitted date:
01/27/2023

Accepted date:
07/20/2023

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
65567a56a953954ddc2490e6 jvb Articles
Links & Downloads

J Vasc Bras

Share this page
Page Sections